{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:18:59Z","timestamp":1789993139984,"version":"4.0.1"},"reference-count":24,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:00:00Z","timestamp":1216252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Blood donor testing for antibody to hepatitis B core antigen (anti\u2010HBc) has been used in the United States for more than 20 years as a surrogate to prevent transmission by transfusion of non\u2010A,non\u2010B hepatitis, as a human immunodeficiency virus surrogate, and to reduce transmission of hepatitis B virus (HBV). Nonspecific anti\u2010HBc assays have caused deferral of hundreds of thousands of otherwise qualified donors. A more specific anti\u2010HBc test and a sensitive HBV DNA test should permit donor reentry after false\u2010positive anti\u2010HBc.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> A total of 1324 otherwise eligible volunteer donors, deferred for anti\u2010HBc reactivity on more than one occasion, were recruited from four collection facilities. They were tested using a licensed, more specific anti\u2010HBc test, a licensed hepatitis B surface antigen (HBsAg) test, and a licensed HBV DNA assay with a 95 percent limit of detection of not more than 10 copies per mL.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> From 11 to 32 percent of donors contacted by participating sites entered the study. Overall, 488 (37%) of the donors were negative on the more specific anti\u2010HBc test. The proportion of putative false\u2010positive samples varied according to the test responsible for the original deferral. A single donor, negative for the presence of anti\u2010HBc and HBsAg, was positive for the presence of HBV DNA in one of three replicates. Repeat testing of this donor 10 months later was negative for the presence of all markers of HBV infection, and the donor had a history of HBV vaccination with documented postimmunization anti\u2010HBs seroconversion 10 years before her anti\u2010HBc deferral, and was considered HBV DNA false positive.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> These data support reentry of donors with false\u2010positive anti\u2010HBc results on the relatively nonspecific assays that have been in use in the United States for more than 20 years.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.01844.x","type":"journal-article","created":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T15:32:37Z","timestamp":1216308757000},"page":"2315-2322","source":"Crossref","is-referenced-by-count":31,"title":["Performance of an algorithm for the reentry of volunteer blood donors deferred due to false\u2010positive test results for antibody to hepatitis B core antigen"],"prefix":"10.1111","volume":"48","author":[{"given":"Louis","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Michael","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tegtmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Stramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,3]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"2977","volume-title":"Fields virology","author":"Seeger C","year":"2007"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212202"},{"key":"e_1_2_6_4_2","first-page":"11S","article-title":"Contribution of anti\u2010HBc screening to blood safety at a regional blood center in the United States [Abstract S439","volume":"37","author":"Tegtmeier G","year":"1997","journal-title":"Transfusion"},{"key":"e_1_2_6_5_2","volume-title":"Recommendations concerning testing for antibody to hepatitis B core antigen (Anti\u2010HBc)","author":"Food and Drug Administration","year":"1991"},{"key":"e_1_2_6_6_2","unstructured":"Infectious disease testing for blood transfusions.NIH Consensus Statement1995;13:1\u201029."},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35195090661.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00391.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00406.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2003.12.003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2008.01017.x"},{"issue":"9","key":"e_1_2_6_12_2","first-page":"21A","article-title":"HBV DNA PCR positive rates of antibody to hepatitis B core (anti\u2010HBc) repeat reactive (RR) donors; implications for reentry protocols [abstract","volume":"46","author":"Stramer SL","year":"2006","journal-title":"Transfusion"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00128.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01276.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.371098016437.x"},{"key":"e_1_2_6_16_2","volume-title":"FDA's current thinking on reentry of donors deferred for repeated detection of antibody to hepatitis B core antigen: Blood Products Advisory Committee","author":"Food and Drug Administration. Blood Products Advisory Committee","year":"2004"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00391.x"},{"key":"e_1_2_6_18_2","volume-title":"Recommendations for the quarantine and disposition of units from prior collections from donors with repeatedly reactive screening tests for hepatitis B virus (HBV), hepatitis C virus (HCV) and human T\u2010lymphotropic virus type I (HTLV\u2010I)","author":"Food and Drug Administration","year":"1996"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33593255593.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00818.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(99)00128-3"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00198.x"},{"key":"e_1_2_6_23_2","volume-title":"Product approval information\u2014licensing action","author":"Food and Drug Administration","year":"2005"},{"key":"e_1_2_6_24_2","volume-title":"Guidance for industry, November 2007. Adequate and appropriate donor screening tests for hepatitis B; hepatitis B surface antigen (HBsAg) assays used to test donors of whole blood and blood components, including source plasma and source leukocytes","author":"Food and Drug Administration","year":"2007"},{"key":"e_1_2_6_25_2","first-page":"26A","article-title":"HBV DNA testing and reinstatement of donors deferred for anti\u2010HBc [Abstract S88","volume":"43","author":"Gallarda JL","year":"2003","journal-title":"Transfusion"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.01844.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.01844.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:57:24Z","timestamp":1697252244000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.01844.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1537-2995.2008.01844.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01844.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}